Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Catharina Svanborg

Showing results (51-60 of 117) with videos related to

Pageof 12
Sort By:
The Journal of Nutrition|May 4, 2005
HAMLET kills tumor cells by apoptosis: structure, cellular mechanisms, and therapyLotta Gustafsson, Oskar Hallgren, Ann-Kristin Mossberg, et al.
Cancer Research|December 7, 2007
Histone deacetylase inhibitors promote the tumoricidal effect of HAMLETPatrick Brest, Mattias Gustafsson, Ann-Kristin Mossberg, et al.
Advances in Experimental Medicine and Biology|May 25, 2002
Hamlet--a complex from human milk that induces apoptosis in tumor cells but spares healthy cellsMalin Svensson, Caroline Düringer, Oskar Hallgren, et al.
Nature Microbiology|February 12, 2026
Targeted innate immune inhibition therapy compared with antibiotics for recurrent acute cystitis: a randomized, open-label phase 2 trialInes Ambite, Adrian Pilatz, Mareike Buch-Heberling, et al.
Cancer Research|March 18, 2004
Human alpha-lactalbumin made lethal to tumor cells (HAMLET) kills human glioblastoma cells in brain xenografts by an apoptosis-like mechanism and prolongs survivalWalter Fischer, Lotta Gustafsson, Ann-Kristin Mossberg, et al.
Advances in Experimental Medicine and Biology|January 11, 2008
Apoptosis and tumor cell death in response to HAMLET (human alpha-lactalbumin made lethal to tumor cells)Oskar Hallgren, Sonja Aits, Patrick Brest, et al.
The Journal of Urology|August 6, 2013
Rare emergence of symptoms during long-term asymptomatic Escherichia coli 83972 carriage without an altered virulence factor repertoireBéla Köves, Ellaine Salvador, Jenny Grönberg-Hernández, et al.
The Journal of Pharmacology and Experimental Therapeutics|January 10, 2009
Therapeutic effect of blocking CXCR2 on neutrophil recruitment and dextran sodium sulfate-induced colitisShukkur Muhammed Farooq, RoseMarie Stillie, Majlis Svensson, et al.
The American Journal of Pathology|October 4, 2008
Shiga toxin-mediated disease in MyD88-deficient mice infected with Escherichia coli O157:H7Carla Calderon Toledo, Trisha Jayne Rogers, Majlis Svensson, et al.
Plos One|March 17, 2011
HAMLET binding to α-actinin facilitates tumor cell detachmentMaria Trulsson, Hao Yu, Lennart Gisselsson, et al.
Pageof 12

Showing results (51-60 of 117) with videos related to

Sort By:
Pageof 12
The Journal of Nutrition|May 4, 2005
HAMLET kills tumor cells by apoptosis: structure, cellular mechanisms, and therapyLotta Gustafsson, Oskar Hallgren, Ann-Kristin Mossberg, et al.
Cancer Research|December 7, 2007
Histone deacetylase inhibitors promote the tumoricidal effect of HAMLETPatrick Brest, Mattias Gustafsson, Ann-Kristin Mossberg, et al.
Advances in Experimental Medicine and Biology|May 25, 2002
Hamlet--a complex from human milk that induces apoptosis in tumor cells but spares healthy cellsMalin Svensson, Caroline Düringer, Oskar Hallgren, et al.
Nature Microbiology|February 12, 2026
Targeted innate immune inhibition therapy compared with antibiotics for recurrent acute cystitis: a randomized, open-label phase 2 trialInes Ambite, Adrian Pilatz, Mareike Buch-Heberling, et al.
Cancer Research|March 18, 2004
Human alpha-lactalbumin made lethal to tumor cells (HAMLET) kills human glioblastoma cells in brain xenografts by an apoptosis-like mechanism and prolongs survivalWalter Fischer, Lotta Gustafsson, Ann-Kristin Mossberg, et al.
Advances in Experimental Medicine and Biology|January 11, 2008
Apoptosis and tumor cell death in response to HAMLET (human alpha-lactalbumin made lethal to tumor cells)Oskar Hallgren, Sonja Aits, Patrick Brest, et al.
The Journal of Urology|August 6, 2013
Rare emergence of symptoms during long-term asymptomatic Escherichia coli 83972 carriage without an altered virulence factor repertoireBéla Köves, Ellaine Salvador, Jenny Grönberg-Hernández, et al.
The Journal of Pharmacology and Experimental Therapeutics|January 10, 2009
Therapeutic effect of blocking CXCR2 on neutrophil recruitment and dextran sodium sulfate-induced colitisShukkur Muhammed Farooq, RoseMarie Stillie, Majlis Svensson, et al.
The American Journal of Pathology|October 4, 2008
Shiga toxin-mediated disease in MyD88-deficient mice infected with Escherichia coli O157:H7Carla Calderon Toledo, Trisha Jayne Rogers, Majlis Svensson, et al.
Plos One|March 17, 2011
HAMLET binding to α-actinin facilitates tumor cell detachmentMaria Trulsson, Hao Yu, Lennart Gisselsson, et al.
Pageof 12